Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
From 1995 to 2016, hepatocellular carcinoma incidence in rural populations climbed by 218%.
Cirrhosis severity and CD4 cell counts were linked to a greater chance of developing liver cancer.
Use of cholesterol-lowering medications was also associated with reduced mortality from liver cancer and other causes.
An advisory panel reviewed follow-up data on checkpoint inhibitors, voting to maintain four approvals and rescind two.
In a small study, 80% of participants treated with Cabometyx and Opdivo underwent successful surgery.
People treated with direct-acting antivirals had better overall survival than those whose hepatitis C remained untreated.
But a simple improvement in dietary intake reversed fatty liver disease and staved off cancer.
Sintilimab plus chemotherapy infused into a liver artery may offer the chance for a cure.
Suppression of hepatitis B virus with antiviral treatment lowered the risk of hepatocellular carcinoma by 58%.
People with NAFLD have an elevated risk of cancer, largely due to high liver cancer incidence.
Weight-loss surgery especially reduced obesity-related cancers in people with liver cirrhosis.
People living with both viruses remain at risk for hepatocellular carcinoma despite antiviral therapy.
Blue Faery’s “Love Your Liver” 28-day video campaign raises awareness of liver cancer and overall liver health.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.